ENDRA Life Sciences (NDRA) Non Operating Income (2017 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Non Operating Income of $862315.0 for Q1 2026, up 99.17% year-over-year from $432952.0 in Q1 2025, and up 155.73% quarter-over-quarter from -$1.5 million in Q4 2025.
ENDRA Life Sciences (NDRA) Non Operating Income (2017 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Non Operating Income for 10 consecutive years, with $862315.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 99.17% year-over-year to $862315.0; the TTM figure through Mar 2026 stood at -$477172.0 (down 81.65% YoY), while the FY2025 annual figure was -$1.3 million, down 83.02% from the prior year.
- Non Operating Income advanced to $862315.0 in Q1 2026 per NDRA's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Non Operating Income topped out at $862315.0 in Q1 2026 and bottomed at -$1.5 million in Q4 2025.
- Historically, Non Operating Income has averaged -$48924.1 across 5 years, with a median of -$1756.0 in 2023.
- On a YoY basis, Non Operating Income climbed as much as 8513.15% in 2024 and fell as far as 3093.96% in 2024.
- ENDRA Life Sciences' Non Operating Income stood at $23785.0 in 2022, then tumbled by 107.38% to -$1756.0 in 2023, then jumped by 8513.15% to $147735.0 in 2024, then plunged by 1147.27% to -$1.5 million in 2025, then soared by 155.73% to $862315.0 in 2026.
- Business Quant data shows NDRA's Non Operating Income at $862315.0 in Q1 2026, -$1.5 million in Q4 2025, and -$225256.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | - |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | - |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | 15.00 Mn |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | -63.00 Mn |
| 10 | ENDRA Life Sciences | 5.48 Mn | 5.13 Mn | - | 862,315.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 862,315.00 |
| Dec 31, 2025 | -1.55 Mn |
| Sep 30, 2025 | -225,256.00 |
| Mar 31, 2025 | 432,952.00 |
| Dec 31, 2024 | 147,735.00 |
| Sep 30, 2024 | -845,076.00 |
| Jun 30, 2024 | 1,700.00 |
| Dec 31, 2023 | -1,756.00 |
| Sep 30, 2023 | 28,226.00 |
| Jun 30, 2023 | 437,433.00 |
| Mar 31, 2023 | -3,418.00 |
| Dec 31, 2022 | 23,785.00 |
| Sep 30, 2022 | -23,011.00 |
| Jun 30, 2022 | -19,374.00 |
| Mar 31, 2022 | -2,933.00 |
| Dec 31, 2021 | -33,087.00 |
| Sep 30, 2021 | -7,507.00 |
| Jun 30, 2021 | 1,086.00 |
| Mar 31, 2021 | 306,563.00 |
| Dec 31, 2020 | 3,581.00 |